2025 Notice of Annual General Meeting
Released
Released
Announcement PDF
2025 Notice of Annual General Meeting
Sydney, Australia – Tetratherix Limited (ASX: TTX) attaches the following documents relating
to its 2025 Annual General Meeting to be held as a hybrid meeting at 1:00pm (AEDT) on
Monday, 10 November 2025:
- Notice of Annual General Meeting
- Proxy Form
- Access Letter
< ENDS >
Authorised for ASX release by the Board of Directors of Tetratherix Limited.
For further information, please contact:
Matthew Wright
NWR Communications
+61 (0) 451 896 420
matt@nwrcommunications.com.au
https://tetratherix.com/
ASX ANNOUNCEMENT
9 October 2025
Doc 1401327827.1
Tetratherix Limited
Unit 29,
34-36 Ralph Street
Alexandria
NSW 2015
Tetratherix Limited
Notice of 2025 Annual General Meeting
Explanatory Statement | Proxy Form
Monday, 10 November 2025
1.00PM AEDT
Virtual Meeting & held at
Automic Group
Level 5
126 Phillip Street Sydney
NSW 2000
www.tetratherix.com
This Notice of Meeting should be read in its
entirety. If Shareholders are in doubt as to how
they should vote, they should seek advice from
their professional advisers prior to voting.
Tetratherix Limited | Annual General Meeting – Notice of Meeting and Explanatory Statement 2
Doc 1401327827.1
Contents
Venue and Voting Information 2
Notice of Annual General Meeting – Agenda and Resolutions 5
Notice of Annual General Meeting – Explanatory Statement 10
Glossary 19
Annexure A – Audit Nomination Letter Attached
Proxy Form Attached
Important Information for Shareholders about the Company’s 2025 AGM
This Notice is given based on circumstances as at 2 October 2025. Should circumstances change,
the Company will make an announcement on the ASX market announcements platform and on
the Company’s website at www.tetratherix.com. Shareholders are urged to monitor the ASX
announcements platform and the Company’s website.
Venue and Voting Information
The Annual General Meeting of the Shareholders to which this Notice of Meeting relates will be
held at 1.00pm (AEDT) on Monday, 10 November 2025 at Automic, Level 5, 126 Phillip Street,
Sydney, NSW 2000 and as a virtual meeting.
To be able to hold this Meeting at both a physical and virtual venue, the Company is relying upon
s249R(b) of the Corporations Act.
The company is pleased to provide shareholders with the opportunity to attend and participate
in a virtual Meeting through an online meeting platform powered by Automic.
Shareholders that have an existing account with Automic will be able to watch, listen and vote
online.
Shareholders who do not have an account with Automic are strongly encouraged to register for
an account as soon as possible and well in advance of the Meeting to avoid any delays on the
day of the Meeting.
An account can be created via the following link investor.automic.com.au and then clicking on
“register” and following the prompts. Shareholders will require their holder number
(Securityholder Reference Number (SRN) or Holder Identification Number (HIN)) to create an
account with Automic.
To access the virtual meeting on the day:
1. Open your internet browser and go to investor.automic.com.au
2. Login with your username and password or click “register” if you haven’t already created
an account. Shareholders are encouraged to create an account prior to the start of
the meeting to ensure there is no delay in attending the virtual meeting
3. After logging in, a banner will display at the bottom of your screen to indicate that the
meeting is open for registration, click on “Register” when this appears. Alternatively, click
on “Meetings” on the left-hand menu bar to join the meeting.
4. Click on “Join Meeting” and follow the prompts on screen to register and vote.
Tetratherix Limited | Annual General Meeting – Notice of Meeting and Explanatory Statement 3
Doc 1401327827.1
Shareholders will be able to vote (see the “Voting virtually at the Meeting” section of this Notice
of Meeting below) and ask questions at the virtual meeting.
Shareholders are also encouraged to submit questions in advance of the Meeting to the
Company.
Questions must be submitted in writing to Jacob Pfeffer at jacob.pfeffer@tetratherix.com at least
48 hours before the AGM.
The Company will also provide Shareholders with the opportunity to ask questions during the
Meeting in respect to the formal items of business as well as general questions in respect to the
Company and its business.
Your vote is important
The business of the Annual General Meeting affects your shareholding and your vote is important.
Voting in person
To vote in person, attend the Annual General Meeting on the date and at the place set out above.
Voting virtually at the Meeting
Shareholders who wish to vote virtually on the day of the AGM can do so by logging in to the
Automic shareholder portal.
1. Open your internet browser and go to investor.automic.com.au
2. Login using your username and password. If you do not already have an account, click
“Register” and follow the prompts. Shareholders are encouraged to register prior to
the commencement of the Meeting to avoid delays in accessing the virtual platform.
3. After logging in, a banner will appear at the bottom of your screen when the Meeting is
open for registration. Click “Register”. Alternatively, select Meetings from the left-hand
menu.
4. Click on “Join Meeting” and follow the prompts.
5. When the Chair of the Meeting declares the poll open, select the “Voting” dropdown menu
on the right-hand side of your screen.
6. Select either the “Full” or “Allocate” option to access your electronic voting card.
7. Follow the prompts to record your voting direction for each resolution and click “Submit
votes”. For allocated votes, the number of votes submitted must not exceed your
remaining available units. Important: Votes cannot be amended once submitted.
For further information on the live voting process please see the Registration and Voting Guide
at https://www.automicgroup.com.au/virtual-agms/
It is recommended that Shareholders wishing to attend the Meeting login from 12.45pm on 10
November 2025, being 15 minutes before the Meeting is scheduled to start.
Voting by proxy
To vote by proxy, please use one of the following methods:
Online Lodge the Proxy Form online at https://investor.automic.com.au/#/loginsah by
following the instructions: Login to the Automic website using the holding details as
shown on the Proxy Form. Click on ‘View Meetings’ – ‘Vote’. To use the online
lodgement facility, Shareholders will need their holder number (Securityholder
Tetratherix Limited | Annual General Meeting – Notice of Meeting and Explanatory Statement 4
Doc 1401327827.1
Reference Number (SRN) or Holder Identification Number (HIN)) as shown on the
front of the Proxy Form.
For further information on the online proxy lodgement process please see the
Online Proxy Lodgement Guide at https://www.automicgroup.com.au/virtual-
agms/
By post Automic, GPO Box 5193, Sydney NSW 2001
By hand Automic, Level 5, 126 Phillip Street, Sydney NSW 2000
By email Completing the enclosed Proxy Form and emailing it to:
meetings@automicgroup.com.au
Your Proxy instruction must be received not later than 48 hours before the commencement of the
Meeting. Proxy Forms received later than this time will be invalid.
Power of Attorney
If the proxy form is signed under a power of attorney on behalf of a shareholder, then the attorney
must make sure that either the original power of attorney or a certified copy is sent with the proxy
form, unless the power of attorney has already provided it to the Share Registry.
Corporate Representatives
If a representative of a corporate shareholder or a corporate proxy will be attending the Meeting,
the representative should bring to the Meeting adequate evidence of their appointment, unless
this has previously been provided to the Share Registry.
Tetratherix Limited | Annual General Meeting – Notice of Meeting and Explanatory Statement 5
Doc 1401327827.1
Notice of Annual General Meeting
Notice is hereby given that an Annual General Meeting of Shareholders of Tetratherix Limited ACN
607 771 077 will be held at 1.00pm (AEDT) on Monday, 10 November 2025 at Automic, Level 5, 126
Phillip Street, Sydney NSW 2000 and as a virtual meeting (Meeting).
The Explanatory Statement to this Notice of Meeting provides additional information on matters
to be considered at the Annual General Meeting. The Explanatory Statement and the Proxy Form
forms part of this Notice of Meeting.
The Directors have determined pursuant to Regulation 7.11.37 of the Corporations Regulations
2001 (Cth) that the persons eligible to vote at the Annual General Meeting are those who are
registered Shareholders at 1.00pm (AEDT) on Saturday, 8 November 2025.
Terms and abbreviations used in this Notice of Meeting and Explanatory Statement are defined in
the Glossary.
Agenda
Ordinary business
Financial statements and reports
“To receive and to consider the Annual Financial Report of the Company for the financial year ended 30
June 2025 together with the declaration of the Directors, the Directors’ Report, the Remuneration Report
and the Auditor’s Report for that financial year.”
Note: This item of ordinary business is for discussion only and is not a resolution.
Pursuant to the Corporations Act, Shareholders will be given a reasonable opportunity at the
Meeting to ask questions about, or make comments in relation to, each of the aforementioned
reports during consideration of these items.
Tetratherix Limited | Annual General Meeting – Notice of Meeting and Explanatory Statement 6
Doc 1401327827.1
Resolutions
Remuneration Report
1. Resolution 1 – Adoption of Remuneration Report
To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution:
“That, for the purpose of Section 250R(2) of the Corporations Act and for all other purposes,
approval is given for the adoption of the Remuneration Report as contained in the Company’s
Annual Financial Report for the financial year ended 30 June 2025.”
Note: The vote on this Resolution is advisory only and does not bind the Directors or the
Company.
Voting Exclusion Statement: In accordance with the Corporations Act, the Company will
disregard any votes cast on Resolution 1 by or on behalf of a member of the Company’s
key management personnel (including the Directors), whose remuneration details are
included in the Remuneration Report (KMP), or any of that person’s Closely Related
Parties (such as close family members and any controlled companies of those persons)
(collectively referred to as Restricted Voter). However, the Company need not disregard a
vote if:
(a) it is cast by a person as a proxy appointed in writing that specifies how the proxy is
to vote on Resolution 1; and
(b) it is not cast on behalf of a Restricted Voter.
If you appoint the person chairing the Meeting (Chair) and you are not a Restricted Voter,
by submitting the Proxy Form you authorise the person chairing the Meeting to exercise
the proxy even though Resolution 1 is connected directly or indirectly with the
remuneration of a KMP, and you will be taken to have directed the Chair to vote in
accordance with his or her stated intention to vote in favour of Resolution 1. If you do not
want your vote exercised in favour of Resolution 1, you should direct the person chairing
the Meeting to vote “against”, or to abstain from voting on, this Resolution.
Tetratherix Limited | Annual General Meeting – Notice of Meeting and Explanatory Statement 7
Doc 1401327827.1
Re-election of Directors
2. Resolution 2 – Election of William Knox as Director
To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution:
“That William Knox, a Director appointed as an additional Director and holding office until the
next general meeting of the Company after his appointment in accordance with the Company’s
Constitution and ASX Listing Rule 14.4, be elected as a Director of the Company, effective
immediately.”
3. Resolution 3 – Election of Emma Cleary as Director
To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution:
“That Emma Cleary, a Director appointed as an additional Director and holding office until the
next general meeting of the Company after her appointment in accordance with the Company’s
Constitution and ASX Listing Rule 14.4, be elected as a Director of the Company, effective
immediately.”
4. Resolution 4 – Election of Gillian Shea as Director
To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution:
“That Gillian Shea, a Director appointed as an additional Director and holding office until the next
general meeting of the Company after her appointment in accordance with the Company’s
Constitution and ASX Listing Rule 14.4, be elected as a Director of the Company, effective
immediately.”
5. Resolution 5 – Election of Atlanta Daniel as Director
To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution:
“That Atlanta Daniel, a Director appointed as an additional Director and holding office until the
next general meeting of the Company after her appointment in accordance with the Company’s
Constitution and ASX Listing Rule 14.4, be elected as a Director of the Company, effective
immediately.”
6. Resolution 6 – Election of John Kelly as Director
To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution:
“That John Kelly, a Director appointed as an additional Director and holding office until the next
general meeting of the Company after his appointment in accordance with the Company’s
Constitution and ASX Listing Rule 14.4, be elected as a Director of the Company, effective
immediately.”
7. Resolution 7 – Election of David Bottomley as Director
To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution:
“That David Bottomley, a Director appointed as an additional Director and holding office until the
next general meeting of the Company after his appointment in accordance with the Company’s
Constitution and ASX Listing Rule 14.4, be elected as a Director of the Company, effective
immediately.”
8. Resolution 8 – Election of Ali Fathi as Director
To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution:
“That Ali Fathi, a Director appointed as an additional Director and holding office until the next
general meeting of the Company after his appointment in accordance with the Company’s
Tetratherix Limited | Annual General Meeting – Notice of Meeting and Explanatory Statement 8
Doc 1401327827.1
Constitution and ASX Listing Rule 14.4, be elected as a Director of the Company, effective
immediately.”
ASX Listing Rule 7.1A (Additional 10% Capacity)
9. Resolution 9 – ASX Listing Rule 7.1A Approval of Future Issue of
Securities
To consider and, if thought fit, to pass the following resolution as a Special Resolution:
“That, for the purposes of ASX Listing Rule 7.1A and for all other purposes, the Shareholders
approve the issue of equity securities up to 10% of the issued capital of the Company (at the time
of issue) calculated in accordance with the formula prescribed in ASX Listing Rule 7.1A.2 and
otherwise on the terms and conditions set out in the Explanatory Statement which accompanies
and forms part of this Notice of Meeting.”
Voting Exclusion Statement: The Company will disregard any votes cast in favour of
Resolution 9 by or on behalf of:
(a) a person who is expected to participate in, or who will obtain a material benefit as
a result of, the proposed issue (except a benefit solely by reason of being a holder
of ordinary securities in the Company); or
(b) an Associate of that person or those persons.
However, this does not apply to a vote cast in favour of Resolution 9 by:
(i) a person as proxy or attorney for a person who is entitled to vote on the Resolution,
in accordance with directions given to the proxy or attorney to vote on the
Resolution in that way; or
(ii) the Chair of the Meeting as proxy or attorney for a person who is entitled to vote
on the Resolution, in accordance with a direction given to the Chair to vote on the
Resolution as the Chair decides; or
(iii) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on
behalf of a beneficiary provided the following conditions are met:
• the beneficiary provides written confirmation to the holder that the beneficiary
is not excluded from voting, and is not an associate of a person excluded from
voting, on the Resolution; and
• the holder votes on the Resolution in accordance with directions given by the
beneficiary to the holder to vote in that way.
Appointment of Auditor
10. Resolution 10 – Appointment of Auditor
To consider and if thought fit, to pass the following resolution as an Ordinary Resolution:
“That, for the purposes of section 327B(1) of the Corporations Act and for all other purposes,
Nexia Sydney Audit Pty Ltd ACN 606 785 399 having been nominated by shareholders and
consented in writing to act as auditor of the Company, be appointed as auditor of the Company,
effective immediately.”
Tetratherix Limited | Annual General Meeting – Notice of Meeting and Explanatory Statement 9
Doc 1401327827.1
BY ORDER OF THE BOARD
Sally Greenwood
Joint Company Secretary
Tetratherix Limited | Annual General Meeting – Notice of Meeting and Explanatory Statement 10
Doc 1401327827.1
Explanatory Statement
This Explanatory Statement has been prepared for the information of the Shareholders in
connection with the business to be conducted at the Annual General Meeting to be held at 1.00pm
(AEDT) on Monday, 10 November 2025 at Automic, Level 5, 126 Phillip Street, Sydney NSW 2000 at
and as a virtual meeting.
The purpose of this Explanatory Statement is to provide information which the Directors believe
to be material to Shareholders in deciding whether or not to pass the Resolutions in the Notice of
Meeting.
If you are in any doubt about what to do in relation to the Resolutions contemplated in the Notice
of Meeting and this Explanatory Statement, it is recommended that you seek advice from an
accountant, solicitor or other professional advisor.
Full details of the business to be considered at the Annual General Meeting are set out below.
Agenda
Ordinary business
Financial statements and reports
In accordance with the Constitution and the Corporations Act, the business of the Annual General
Meeting will include receipt and consideration of the Annual Financial Report of the Company for
the financial year ended 30 June 2025 together with the declaration of the Directors, the Director’s
Report, the Remuneration Report and the Auditor’s Report.
In accordance with the amendments to the Corporations Act, the Company is no longer required
to provide a hard copy of the Company’s Annual Financial Report to Shareholders unless a
Shareholder has specifically elected to receive a printed copy.
Whilst the Company will not provide a hard copy of the Company’s Annual Financial Report unless
specifically requested to do so, Shareholders may view the Company Annual Financial Report on
its website at www.tetratherix.com.
No resolution is required for this item, but Shareholders will be given the opportunity to ask
questions and to make comments on the management and performance of the Company.
The Company’s auditor will be present at the Meeting. During the discussion of this item, the
auditor will be available to answer questions on the:
Conduct of the audit;
Preparation and content of the Auditor’s Report;
Accounting policies adopted by the Company in relation to the preparation of the financial
statements; and
Independence of the auditor in relation to the conduct of the audit.
Written questions of the auditor
If you would like to submit a written question about the content of the Auditor’s Report or the
conduct of the audit of the Annual Financial Report by the Company’s auditor, please send your
question to the Company Secretary. A list of qualifying questions will be made available at the
Meeting.
Please note that all written questions must be received at least five business days before the
Meeting, which is by 3 November 2025.
Tetratherix Limited | Annual General Meeting – Notice of Meeting and Explanatory Statement 11
Doc 1401327827.1
Resolutions
Remuneration Report
Resolution 1 – Adoption of Remuneration
In accordance with section 250R(2) of the Corporations Act, the Company is required to present to
its Shareholders the Remuneration Report as disclosed in the Company’s Annual Financial Report.
The vote on the Resolution is advisory only and does not bind the Directors or the Company. The
Remuneration Report is set out in the Company’s Annual Financial Report and is also available on
the Company’s website at www.tetratherix.com.
However, if at least 25% of the votes cast are against the adoption of the Remuneration Report at
the Meeting (subject of this Notice of Meeting), and then again at the 2026 Annual General Meeting
(2026 AGM), the Company will be required to put to the vote a resolution (Spill Resolution) at the
2026 AGM to approve the calling of a further meeting (Spill Meeting). If more than 50% of
Shareholders vote in favour of the Spill Resolution, the Company must convene the Spill Meeting
within 90 days of the 2026 AGM. All of the Directors who were in office when the 2026 Directors’
Report was approved, other than the Managing Director, will (if desired) need to stand for re-
election at the Spill Meeting.
The Remuneration Report explains the Board’s policies in relation to the nature and level of
remuneration paid to KMPs (including Directors) and sets out remuneration details, service
agreements and the details of any share-based compensation.
Voting
Note that a voting exclusion applies to Resolution 1 in the terms set out in the Notice of Meeting.
In particular, the Directors and other Restricted Voters must not vote on this Resolution and must
not cast a vote as proxy, unless the appointment gives a direction on how to vote, or the proxy is
given to the Chair and you submit the Proxy Form, authorising the Chair to exercise the proxy even
though Resolution 1 is connected directly or indirectly with the remuneration of a KMP and that in
doing so you will be taken to have directed the Chair to vote in accordance with the Chair’s stated
intention to vote in favour of Resolution 1.
Shareholders are urged to read carefully the Proxy Form and to provide a direction to the proxy
on how to vote on this Resolution.
Resolution 2 – Election of William Knox as Director
The Company’s Constitution provides that any Director appointed in addition to the existing
Directors will hold office until the next following annual general meeting and is then eligible for re-
election.
ASX Listing Rule 14.4 also provides that each additional director appointed during the year is to
hold office until the next annual general meeting and is then eligible for election as a Director of
the Company.
William Knox was appointed as an additional Director of the Company on 28 August 2021 and has
since served as a Director of the Company.
Under this Resolution, William Knox seeks election as a Director of the Company at this AGM.
William has over 20 years of leadership experience in the commercial development of medical
technologies and healthcare innovations. His previous role was Senior Business Manager for
Device Technologies following their acquisition of uHealth in 2017 - a regenerative biologic
Tetratherix Limited | Annual General Meeting – Notice of Meeting and Explanatory Statement 12
Doc 1401327827.1
company he established in 2013. Prior to founding uHealth, William has held commercial
leadership roles at Cochlear (ASX:COH), Medtronic (NYSE:MDT) and LifeHealthcare.
William holds a Bachelor of Medical Science (B.MedSc) from the University of Technology Sydney,
graduated from the Wharton School's Executive development Program and is a member of the
Australian Institute of Company Directors (MAICD).
Directors’ recommendation
The Directors (excluding Wiliam Knox) recommend that Shareholders vote for this Resolution.
Resolution 3 – Election of Emma Cleary as Director
The Company’s Constitution provides that any Director appointed in addition to the existing
Directors will hold office until the next following annual general meeting and is then eligible for re-
election.
ASX Listing Rule 14.4 also provides that each additional director appointed during the year is to
hold office until the next annual general meeting and is then eligible for election as a Director of
the Company.
Emma Cleary was appointed as an additional Director of the Company on 13 March 2025 and has
since served as a Director of the Company.
Under this Resolution, Emma Cleary seeks election as a Director of the Company at this AGM.
Emma holds a Bachelor of Business, Accounting and Economics (Deakin University), is a member
of the Institute of Chartered Accountants of Australia and a graduate of the Australian Institute of
Company Directors. Emma is currently a non-executive director of Device Technologies and has
been with that company for nearly 20 years, previously holding the positions of executive director
/ Chief Operating Officer (2016 to 2020) and Chief Financial Officer (2005 to 2016). During this
period Emma was also non-executive director and vice chair of the Medical Technology Association
of Australia and currently serves as executive director of the Macular Disease Foundation of
Australia.
Directors’ recommendation
The Directors (excluding Emma Cleary) recommend that Shareholders vote for this Resolution.
Resolution 4 – Election of Gillian Shea as Director
The Company’s Constitution provides that any Director appointed in addition to the existing
Directors will hold office until the next following annual general meeting and is then eligible for re-
election.
ASX Listing Rule 14.4 also provides that each additional director appointed during the year is to
hold office until the next annual general meeting and is then eligible for election as a Director of
the Company.
Gillian Shea was appointed as an additional Director of the Company on 13 March 2025 and has
since served as a Director of the Company.
Under this Resolution, Gillian Shea seeks election as a Director of the Company at this AGM.
Gillian holds a Bachelor of Business, Accounting and Finance (University of Technology Sydney), is
a member of the Institute of Chartered Accounts Australia and New Zealand and a graduate of the
Australian Institute of Company Directors.
Gillian has over 25 years of audit and financial reporting experience and was a Registered
Company Auditor. She was an audit partner at BDO where she had numerous ASX listed clients.
Prior to BDO, Gillian was Director of EY in their Assurance practice. Gillian is also currently a non-
executive director of Macular Disease Foundation Australia and Stone & Chalk Limited, and is also
Tetratherix Limited | Annual General Meeting – Notice of Meeting and Explanatory Statement 13
Doc 1401327827.1
the Chair of the Audit & Risk Committee of the latter.
Directors’ recommendation
The Directors (excluding Gillian Shea) recommend that Shareholders vote for this Resolution.
Resolution 5 – Election of Atlanta Daniel as Director
The Company’s Constitution provides that any Director appointed in addition to the existing
Directors will hold office until the next following annual general meeting and is then eligible for re-
election.
ASX Listing Rule 14.4 also provides that each additional director appointed during the year is to
hold office until the next annual general meeting and is then eligible for election as a Director of
the Company.
Atlanta Daniel was appointed as an additional Director of the Company on 10 April 2025 and has
since served as a Director of the Company.
Under this Resolution, Atlanta Daniel seeks election as a Director of the Company at this AGM.
Atlanta is a General Partner and Managing Director at Radar Ventures, a significant investor in the
Company. A commercially minded venture capital investor, Atlanta co-founded Radar Ventures
with Xero founder Rod Drury. Radar backs early-stage deep tech businesses across medical,
sustainability and defence sectors.
With a career spanning venture investment, enterprise SaaS, consumer technology, and branding,
Atlanta brings deep expertise in scaling innovative, IP-driven businesses.
Previous advisory roles include engagements with AIM, a developer of advanced laser systems
integrated with AI, and Airwallex, a global payments and financial platform.
Directors’ recommendation
The Directors (excluding Atlanta Daniel) recommend that Shareholders vote for this Resolution.
Resolution 6 – Election of John Kelly as Director
The Company’s Constitution provides that any Director appointed in addition to the existing
Directors will hold office until the next following annual general meeting and is then eligible for re-
election.
ASX Listing Rule 14.4 also provides that each additional director appointed during the year is to
hold office until the next annual general meeting and is then eligible for election as a Director of
the Company.
John Kelly was appointed as an additional Director of the Company on 30 May 2025 and has since
served as a Director of the Company.
Under this Resolution, John Kelly seeks election as a Director of the Company at this AGM.
John is a highly accomplished executive and company director with extensive experience in the
medical device industry including from ideation to advance manufacturing and regulatory
approval.
John led Atomo (ASX:AT1) through the development of a novel rapid test platform, securing key
regulatory approvals and its initial public offering on ASX. Prior to that John was COO at ASX-listed
Unilife where he led the creation of the ‘Unifill’ glass prefilled drug delivery device (licensed to
Sanofi Aventis). He also spent five years at ResMed managing the New Produ
Share your feedback
Discover